PUBLIC CONTRACT · 2023
Corretivos da Volémia e outras soluções estéreis
- Contract value
- €101,249.30
- Signed on
- 1 January 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9699063PUBLISHED DESCRIPTION
01000323
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Portalegre, Portalegre
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BAXTER MEDICO - FARMACEUTICA · Tax ID 503347345
- Bidder
- OVERPHARMA - PRODUTOS MEDICOS E FARM. · Tax ID 505792362
- Bidder
- LAB. MEDINFAR- PROD.FARMACEUT. SA · Tax ID 500384045
- Bidder
- LABESFAL-LAB. ALMIRO, SA. · Tax ID 501169580
- Bidder
- B BRAUN MEDICAL LDA · Tax ID 501506543
- Bidder
- Grifols Portugal, Lda · Tax ID 502041285
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €101,249.30
- Procedure base price
- €256,737.82
- Total effective price
- €95,182.76
- Publication date
- 12 January 2023
- Award date
- 23 November 2022
- Signing date
- 1 January 2023
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2020/3 - Corretivos da volémia e outras soluções estéreis
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6097509
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.